MedTrace Logo

Molekule for Allergic Rhinitis/Asthma

NCT03627689 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2019-02-05

No results posted yet for this study

Summary

Exposure to airborne allergens and pollutants is linked to symptom severity of allergies, asthma and other respiratory problems. In this study an air purifier using photo-electrochemical oxidation technology (PECO) will be used in the home environment of study participants. The investigator will assess the reduction of symptoms from allergic rhinitis/conjunctivitis and asthma.

Conditions

  • Asthma
  • Allergic Rhinitis
  • Allergic Conjunctivitis

Interventions

OTHER

Active air purifier in respiratory allergies/asthma

Continuous use of air purifier to improve allergies and asthma control

OTHER

Sham air purifier

control arm

Sponsors & Collaborators

  • Molekule

    lead INDUSTRY

Principal Investigators

  • Nikhil G Rao, MD · Molekule

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-13
Primary Completion
2019-01-31
Completion
2019-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03627689 on ClinicalTrials.gov